PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
TB is the number one cause of death among people living with HIV/AIDS (PLHA). Early diagnosis of TB in
people with HIV, along with prevention of TB transmission, can reduce mortality. Additionally, since
multidrug-resistant (MDR) TB is associated with increased mortality in people with HIV, it is important to
detect MDR TB when present. This calls for enhanced TB diagnostic capacity in PLHA to include quality
smear microscopy, liquid culture, chest radiography services, and drug-susceptibility testing, along with
improved TB infection control.
In recognition of the fact that a strong national HIV program requires there to be an equally strong national
TB control program, HHS/CDC will develop a Cooperative Agreement with the National TB Program (NTP),
based at the National Center for Tuberculosis and Leprosy (CENAT) to complement its Cooperative
Agreement with the National Center for HIV/AIDS, Dermatology and STDs (NCHADS). This narrative
describes the activities planned in partnership with CENAT for COP 09.
The objective of this cooperative agreement is to provide support to improve the diagnosis of TB in PLHA
and to decrease the risk of transmission of TB to people with HIV. Sputum smears are collected in over 900
health centers around the country and then sent to one of 210 microscopy units for staining and reading. A
system for external quality assurance (EQA), including blinded rechecking of these smears, has been
implemented, and USG supported EQA for smear microscopy in 13 of Cambodia's 24 provinces was part of
COP 08. The Global Fund and Japanese government will provide support for EQA in all provinces in the
coming year, but USG will support training and supervision related to quality assurance in the northwest
provinces. This will include two regional TB laboratory workshops for TB laboratory staff and supervisors to
discuss the results of EQA testing of sputum smears and approaches to improvement of smear preparation
and reading.
At this time, there are three TB laboratories in Cambodia with culture capabilities. All three of these
laboratories are using solid media for culture. Presently, USG is in the process of implementing WHO
recommended liquid culture in the Battambang Referral Hospital. Funding from COP 08 was used to
renovate one of the three culture sites, which is a site located in Battambang (a province in the northwest).
The funding also supported technical assistance for liquid culture implementation and a biosafety
consultation to ensure protection of laboratory staff. Remaining COP 08 funding is being used to support
procurement of supplies and equipment needed to implement liquid culture and training of laboratory staff.
With resources from COP 09, the USG will continue to support technical assistance and staff training. In
addition, USG will fund transport of specimens from local HIV care centers to the culture facility and
information systems to capture laboratory data. USG will work with the NTP to develop a policy on the use
of culture of sputum from suspected TB in PLHA.
In the province of Battambang, where HIV care is supported by USG, there is an HIV care facility lacking
services for chest radiography. With funding from COP 09, the USG will support the purchase of chest
radiography equipment and supplies for this site and will support the training needed to implement it.
Finally, USG will support the renovation of some existing TB wards to provide isolation areas for patients
with MDR TB to minimize the risk of transmission to HIV-infected persons cared for in the same facility.
New/Continuing Activity: New Activity
Continuing Activity:
Emphasis Areas
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $5,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.12:
